Cornell University
DEVELOPMENT OF A LIPID NANOPARTICLE-ENCAPSULATED mRNA VACCINE AGAINST CLOSTRIDIUM DIFFICILE INFECTION
Abstract
dc:description.abstractClostridium difficile (C. difficile) infection (CDI) is a significant health risk within hospital settings. C. difficile is an anaerobic gram-positive bacterium that spreads among people via the fecal-oral route. It forms spores and produces toxins in vivo, leading to hospital-acquired diarrhea and colitis, particularly in developed countries. The emergence and proliferation of C. difficile are likely due to the widespread use of antibiotics. This work proposed to develop a lipid nanoparticle-encapsulated, nucleoside-modified mRNA (mRNA-LNP) vaccine against CDI. The mRNA encoded one truncated fragment of the receptor binding domain (RBD) of C. difficile Toxin A. We assessed both humoral and cell-mediated immune responses in mice following immunization. Results showed that the vaccine induced strong humoral and cell-mediated immune responses. By conducting a spore challenge, we confirmed that the robust immune responses provided protection against CDI. This research highlights the potential for creating highly effective mRNA vaccines against bacterial pathogens and serves as a foundational model for future antibacterial mRNA vaccines.
Degree
thesis:*- Name thesis:degree_name
- M.S., Materials Science and Engineering
- Level thesis:degree_level
- Master of Science
- Discipline thesis:degree_discipline
- Materials Science and Engineering
- Grantor
- Cornell University
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Hu, Yuping
- Chair dc:contributor.chair
-
- Jiang, Shaoyi
- Committee member dc:contributor.committeemember
-
- Yang, Rong
Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Dc Identifier Bibid
- 16611819
- Dc Identifier Other
-
ProQuest Submission ID: 12261
ProQuest Publication ID: 31489134